MicroRNAs MiR-218, MiR-125b, and Let-7g predict prognosis in patients with oral cavity squamous cell carcinoma

PLoS ONE

Volumn 9, Issue 7, 2014, Pages

  Peng, Shih Chi ^a   Liao, Chun Ta ^a   Peng, Chien Hua ^a   Cheng, Ann Joy ^a   Chen, Shu Jen ^a   Huang, Chung Guei ^a   Hsieh, Wen Ping ^b   Yen, Tzu Chen ^a  

^a CHANG GUNG UNIVERSITY   (Taiwan)

^b NATIONAL TSING HUA UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

MICRORNA; MICRORNA 125B; MICRORNA 218; MICRORNA LET 7G; MYC PROTEIN; PROTEIN P53; TRANSCRIPTION FACTOR SP1; UNCLASSIFIED DRUG; MIRN125 MICRORNA, HUMAN; MIRN218 MICRORNA, HUMAN; MIRNLET7 MICRORNA, HUMAN;

ARTICLE; CANCER PROGNOSIS; CANCER STAGING; CONTROLLED STUDY; DISEASE FREE SURVIVAL; DISEASE SPECIFIC SURVIVAL; GENE EXPRESSION; GENE REGULATORY NETWORK; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MOUTH SQUAMOUS CELL CARCINOMA; ONCOGENE MYC; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; RISK ASSESSMENT; RNA EXTRACTION; SP1 GENE; SURVIVAL RATE; TISSUE SECTION; TUMOR SUPPRESSOR GENE; VALIDATION PROCESS; GENE EXPRESSION REGULATION; GENETICS; KAPLAN MEIER METHOD; METABOLISM; MORTALITY; MOUTH TUMOR; MULTIVARIATE ANALYSIS; PROGNOSIS; SQUAMOUS CELL CARCINOMA; TUMOR CELL LINE;

CARCINOMA, SQUAMOUS CELL; CELL LINE, TUMOR; DISEASE-FREE SURVIVAL; GENE EXPRESSION; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE REGULATORY NETWORKS; HUMANS; KAPLAN-MEIER ESTIMATE; MICRORNAS; MOUTH NEOPLASMS; MULTIVARIATE ANALYSIS; PROGNOSIS;

EID: 84904633922     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0102403     Document Type: Article

References (51)

1. Jemal A, Bray F, Center MM, Ferlay J, Ward E, et al. (2011) Global cancer statistics. CA Cancer J Clin 61: 69-90.
2. Stucken E, Weissman J, Spiegel JH (2010) Oral cavity risk factors: experts' opinions and literature support. J Otolaryngol Head Neck Surg 39: 76-89.
3. Griffiths-Jones S (2010) miRBase: microRNA sequences and annotation. Curr Protoc Bioinformatics Chapter 12: Unit 12 19 11-10.
4. Huppi K, Volfovsky N, Mackiewicz M, Runfola T, Jones TL, et al. (2007) MicroRNAs and genomic instability. Semin Cancer Biol 17: 65-73. (Pubitemid 46084848)
5. Farazi TA, Spitzer JI, Morozov P, Tuschl T (2011) miRNAs in human cancer. J Pathol 223: 102-115.
6. Garzon R, Calin GA, Croce CM (2009) MicroRNAs in Cancer. Annu Rev Med 60: 167-179.
7. Lu J, Getz G, Miska EA, Alvarez-Saavedra E, Lamb J, et al. (2005) MicroRNA expression profiles classify human cancers. Nature 435: 834-838. (Pubitemid 40839735)
8. Soga D, Yoshiba S, Shiogama S, Miyazaki H, Kondo S, et al. (2013) microRNA expression profiles in oral squamous cell carcinoma. Oncol Rep 30: 579-583.
9. Perez-Sayans M, Pilar GD, Barros-Angueira F, Suarez-Penaranda JM, Fernandez AC, et al. (2012) Current trends in miRNAs and their relationship with oral squamous cell carcinoma. J Oral Pathol Med 41: 433-443.
10. Kozaki K, Imoto I, Mogi S, Omura K, Inazawa J (2008) Exploration of tumor-suppressive microRNAs silenced by DNA hypermethylation in oral cancer. Cancer Res 68: 2094-2105. (Pubitemid 351521781)
11. Yu T, Wang XY, Gong RG, Li A, Yang S, et al. (2009) The expression profile of microRNAs in a model of 7,12-dimethyl-benz[a]anthrance-induced oral carcinogenesis in Syrian hamster. J Exp Clin Cancer Res 28: 64.
12. Wong TS, Liu XB, Wong BY, Ng RW, Yuen AP, et al. (2008) Mature miR-184 as Potential Oncogenic microRNA of Squamous Cell Carcinoma of Tongue. Clin Cancer Res 14: 2588-2592.
13. Henson BJ, Bhattacharjee S, O'Dee DM, Feingold E, Gollin SM (2009) Decreased expression of miR-125b and miR-100 in oral cancer cells contributes to malignancy. Genes Chromosomes Cancer 48: 569-582.
14. Shiiba M, Shinozuka K, Saito K, Fushimi K, Kasamatsu A, et al. (2013) MicroRNA-125b regulates proliferation and radioresistance of oral squamous cell carcinoma. Br J Cancer 108: 1817-1821.
15. Shi LJ, Zhang CY, Zhou ZT, Ma JY, Liu Y, et al. (2014) MicroRNA-155 in oral squamous cell carcinoma: Overexpression, localization, and prognostic potential. Head Neck.
16. Avissar M, Christensen BC, Kelsey KT, Marsit CJ (2009) MicroRNA expression ratio is predictive of head and neck squamous cell carcinoma. Clin Cancer Res 15: 2850-2855.
17. Cervigne NK, Reis PP, Machado J, Sadikovic B, Bradley G, et al. (2009) Identification of a microRNA signature associated with progression of leukoplakia to oral carcinoma. Hum Mol Genet 18: 4818-4829.
18. Chang KW, Liu CJ, Chu TH, Cheng HW, Hung PS, et al. (2008) Association between high miR-211 microRNA expression and the poor prognosis of oral carcinoma. J Dent Res 87: 1063-1068.
19. Krek A, Grun D, Poy MN, Wolf R, Rosenberg L, et al. (2005) Combinatorial microRNA target predictions. Nat Genet 37: 495-500. (Pubitemid 40617277)
20. Doench JG, Sharp PA (2004) Specificity of microRNA target selection in translational repression. Genes Dev 18: 504-511. (Pubitemid 38372808)
21. Cannell IG, Kong YW, Bushell M (2008) How do microRNAs regulate gene expression? Biochem Soc Trans 36: 1224-1231.
22. Huang JC, Babak T, Corson TW, Chua G, Khan S, et al. (2007) Using expression profiling data to identify human microRNA targets. Nat Methods 4: 1045-1049. (Pubitemid 350201777)
23. Watanabe Y, Tomita M, Kanai A (2007) Computational methods for microRNA target prediction. Methods Enzymol 427: 65-86.
24. Peng CH, Liao CT, Peng SC, Chen YJ, Cheng AJ, et al. (2011) A novel molecular signature identified by systems genetics approach predicts prognosis in oral squamous cell carcinoma. PLoS One 6: e23452.
25. Lu YC, Chen YJ, Wang HM, Tsai CY, Chen WH, et al. (2012) Oncogenic function and early detection potential of miRNA-10b in oral cancer as identified by microRNA profiling. Cancer Prev Res (Phila) 5: 665-674.
26. Huang RC, Chang CC, Mold D (2006) Survivin-dependent and -independent pathways and the induction of cancer cell death by tetra-O-methyl nordihydroguaiaretic acid. Semin Oncol 33: 479-485. (Pubitemid 44142741)
27. Heller JD, Kuo J, Wu TC, Kast WM, Huang RC (2001) Tetra-O-methyl nordihydroguaiaretic acid induces G2 arrest in mammalian cells and exhibits tumoricidal activity in vivo. Cancer Res 61: 5499-5504. (Pubitemid 32694933)
28. Chun H, Keles S (2010) Sparse partial least squares regression for simultaneous dimension reduction and variable selection. J R Stat Soc Series B Stat Methodol 72: 3-25.
29. Hsu SD, Lin FM, Wu WY, Liang C, Huang WC, et al. (2011) miRTarBase: a database curates experimentally validated microRNA-target interactions. Nucleic Acids Res 39: D163-169.
30. Papadopoulos GL, Reczko M, Simossis VA, Sethupathy P, Hatzigeorgiou AG (2009) The database of experimentally supported targets: a functional update of TarBase. Nucleic Acids Res 37: D155-158.
31. Chun H, Keles S (2009) Expression quantitative trait loci mapping with multivariate sparse partial least squares regression. Genetics 182: 79-90.
32. Huang da W, Sherman BT, Lempicki RA (2009) Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat Protoc 4: 44-57.
33. Liao CT, Huang SF, Chen IH, Kang CJ, Lin CY, et al. (2010) Outcome analysis of patients with pN2 oral cavity cancer. Ann Surg Oncol 17: 1118-1126.
34. Liao CT, Wang HM, Chang JT, Ng SH, Hsueh C, et al. (2007) Analysis of risk factors for distant metastases in squamous cell carcinoma of the oral cavity. Cancer 110: 1501-1508. (Pubitemid 47463064)
35. Tie J, Pan Y, Zhao L, Wu K, Liu J, et al. (2010) MiR-218 inhibits invasion and metastasis of gastric cancer by targeting the Robo1 receptor. PLoS Genet 6: e1000879.
36. Qian P, Zuo Z, Wu Z, Meng X, Li G, et al. (2011) Pivotal role of reduced let-7g expression in breast cancer invasion and metastasis. Cancer Res 71: 6463-6474.
37. Nam EJ, Yoon H, Kim SW, Kim H, Kim YT, et al. (2008) MicroRNA expression profiles in serous ovarian carcinoma. Clin Cancer Res 14: 2690-2695.
38. Iorio MV, Ferracin M, Liu CG, Veronese A, Spizzo R, et al. (2005) MicroRNA gene expression deregulation in human breast cancer. Cancer Res 65: 7065-7070. (Pubitemid 41161233)
39. Ozen M, Creighton CJ, Ozdemir M, Ittmann M (2008) Widespread deregulation of microRNA expression in human prostate cancer. Oncogene 27: 1788-1793. (Pubitemid 351380263)
40. Boldrup L, Coates PJ, Wahlgren M, Laurell G, Nylander K (2012) Subsite-based alterations in miR-21, miR-125b, and miR-203 in squamous cell carcinoma of the oral cavity and correlation to important target proteins. J Carcinog 11: 18.
41. Fukuchi J, Hiipakka RA, Kokontis JM, Hsu S, Ko AL, et al. (2004) Androgenic suppression of ATP-binding cassette transporter A1 expression in LNCaP human prostate cancer cells. Cancer Res 64: 7682-7685. (Pubitemid 39446896)
42. Yip GW, Smollich M, Gotte M (2006) Therapeutic value of glycosaminoglycans in cancer. Mol Cancer Ther 5: 2139-2148. (Pubitemid 44530449)
43. Bovee JV (2008) Multiple osteochondromas. Orphanet J Rare Dis 3: 3.
44. Fang N, Casida JE (1998) Anticancer action of cube insecticide: correlation for rotenoid constituents between inhibition of NADH:ubiquinone oxidoreductase and induced ornithine decarboxylase activities. Proc Natl Acad Sci U S A 95: 3380-3384. (Pubitemid 28173136)
45. Tozlu-Kara S, Roux V, Andrieu C, Vendrell J, Vacher S, et al. (2007) Oligonucleotide microarray analysis of estrogen receptor alpha-positive postmenopausal breast carcinomas: identification of HRPAP20 and TIMELESS as outstanding candidate markers to predict the response to tamoxifen. J Mol Endocrinol 39: 305-318. (Pubitemid 350047650)
46. Uchikado Y, Inoue H, Haraguchi N, Mimori K, Natsugoe S, et al. (2006) Gene expression profiling of lymph node metastasis by oligomicroarray analysis using laser microdissection in esophageal squamous cell carcinoma. Int J Oncol 29: 1337-1347.
47. Phipps LE, Hino S, Muschel RJ (2011) Targeting cell spreading: a method of sensitizing metastatic tumor cells to TRAIL-induced apoptosis. Mol Cancer Res 9: 249-258.
48. Vigneswaran N, Wu J, Nagaraj N, Adler-Storthz K, Zacharias W (2005) Differential susceptibility of metastatic and primary oral cancer cells to TRAIL-induced apoptosis. Int J Oncol 26: 103-112.
49. Huang M, Narita S, Tsuchiya N, Ma Z, Numakura K, et al. (2011) Overexpression of Fn14 promotes androgen-independent prostate cancer progression through MMP-9 and correlates with poor treatment outcome. Carcinogenesis 32: 1589-1596.
50. Nakaya K, Yamagata HD, Arita N, Nakashiro KI, Nose M, et al. (2007) Identification of homozygous deletions of tumor suppressor gene FAT in oral cancer using CGH-array. Oncogene 26: 5300-5308. (Pubitemid 47237625)
51. Nishikawa Y, Miyazaki T, Nakashiro K, Yamagata H, Isokane M, et al. (2011) Human FAT1 cadherin controls cell migration and invasion of oral squamous cell carcinoma through the localization of beta-catenin. Oncol Rep 26: 587-592.